10 Portions of Produce a Day Can Confer Great Health Benefit

Share this content:
10 Portions of Produce a Day Can Confer Great Health Benefit
10 Portions of Produce a Day Can Confer Great Health Benefit

FRIDAY, Feb. 24, 2017 (HealthDay News) -- Ten daily servings of fruits and vegetables may be a key to reducing the risk of myocardial infarction, stroke, cancer, and premature death, according to a review published online Feb. 22 in the International Journal of Epidemiology.

Together, the 95 studies the Imperial College London scientists analyzed included almost 2 million people. The benefits of high fruit and vegetable consumption appear to come through lower rates of myocardial infarction, stroke, cancer, and early death. And if everyone found a way to get 10 daily servings of produce, 7.8 million premature deaths would be avoided each year worldwide, the researchers estimated.

Even just over two portions a day made a difference in the review, the researchers added. Eating 2.5 portions (200 grams) of produce on a daily basis was associated with reductions in coronary heart disease (by 16 percent); stroke (18 percent); cardiovascular disease (13 percent); cancer risk (4 percent); and premature death (15 percent). The results for 10 daily servings were even stronger: a 24 percent reduced risk of coronary heart disease; a 33 percent reduced risk of stroke; a 28 percent reduced risk of cardiovascular disease; a 13 percent reduced risk of cancer; and a 31 percent reduction in premature death risk.

In their review, the researchers also found signs that the following types of produce seemed to confer the greatest benefits: apples, pears, citrus fruits, green leafy vegetables, cruciferous vegetables (such as broccoli, cabbage, and cauliflower), and green and yellow vegetables (such as green beans, spinach, carrots, and peppers).

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Approves Zejula for Certain Female Cancers

FDA Approves Zejula for Certain Female Cancers

PARP inhibitor may help fight tumors affecting the ovaries, fallopian tubes, or peritoneum

USPSTF: Evidence Lacking for Celiac Dz Screen in Asymptomatic

USPSTF: Evidence Lacking for Celiac Dz Screen in ...

Insufficient evidence for weighing benefits, harms of screening for celiac disease in asymptomatic

Lap, Abdominal Hysterectomy Equal for Early Endometrial CA

Lap, Abdominal Hysterectomy Equal for Early Endometrial CA

Equivalent disease-free survival at 4.5 years for stage I endometrial cancer with TAH, TLH

is free, fast, and customized just for you!

Already a member?

Sign In Now »